Literature DB >> 29725713

Reply to "At what price decreased mortality risk?"

K L Ong1, D P Beall2, M Frohbergh3, E Lau4, J A Hirsch5.   

Abstract

Mesh：

Year:  2018        PMID： 29725713     DOI： 10.1007/s00198-018-4551-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  10 in total

1.  Cost-effectiveness analysis of treatments for vertebral compression fractures.

Authors:  Avram A Edidin; Kevin L Ong; Edmund Lau; Jordana K Schmier; Jason E Kemner; Steven M Kurtz
Journal:  Appl Health Econ Health Policy       Date:  2012-07-01       Impact factor: 2.561

2.  Mortality risk for operated and nonoperated vertebral fracture patients in the medicare population.

Authors:  Avram Allan Edidin; Kevin L Ong; Edmund Lau; Steven M Kurtz
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

3.  Morbidity and Mortality After Vertebral Fractures: Comparison of Vertebral Augmentation and Nonoperative Management in the Medicare Population.

Authors:  Avram Allan Edidin; Kevin L Ong; Edmund Lau; Steven M Kurtz
Journal:  Spine (Phila Pa 1976)       Date:  2015-08-01       Impact factor: 3.468

4.  Analysis of vertebral augmentation practice patterns: a 2016 update.

Authors:  Joshua A Hirsch; Ronil V Chandra; Vidsysagar Pampati; John D Barr; Allan L Brook; Laxmaiah Manchikanti
Journal:  J Neurointerv Surg       Date:  2016-10-31       Impact factor: 5.836

5.  Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading?

Authors:  K L Ong; E Lau; J E Kemner; S M Kurtz
Journal:  Osteoporos Int       Date:  2012-08-08       Impact factor: 4.507

6.  Major medical outcomes with spinal augmentation vs conservative therapy.

Authors:  Brendan J McCullough; Bryan A Comstock; Richard A Deyo; William Kreuter; Jeffrey G Jarvik
Journal:  JAMA Intern Med       Date:  2013-09-09       Impact factor: 21.873

7.  Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data.

Authors:  Ansgar Lange; Christian Kasperk; Luisa Alvares; Sven Sauermann; Sebastian Braun
Journal:  Spine (Phila Pa 1976)       Date:  2014-02-15       Impact factor: 3.468

8.  Mortality following the diagnosis of a vertebral compression fracture in the Medicare population.

Authors:  Edmund Lau; Kevin Ong; Steven Kurtz; Jordana Schmier; Av Edidin
Journal:  J Bone Joint Surg Am       Date:  2008-07       Impact factor: 5.284

9.  Impact of nonoperative treatment, vertebroplasty, and kyphoplasty on survival and morbidity after vertebral compression fracture in the medicare population.

Authors:  Andrew T Chen; David B Cohen; Richard L Skolasky
Journal:  J Bone Joint Surg Am       Date:  2013-10-02       Impact factor: 5.284

10.  Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty "sham" trials?

Authors:  K L Ong; D P Beall; M Frohbergh; E Lau; J A Hirsch
Journal:  Osteoporos Int       Date:  2017-10-24       Impact factor: 4.507
  10 in total
  1 in total

Review 1.  Current status and challenges of percutaneous vertebroplasty (PVP).

Authors:  Tomoyuki Noguchi; Koji Yamashita; Ryotaro Kamei; Junki Maehara
Journal:  Jpn J Radiol       Date:  2022-08-09       Impact factor: 2.701
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.